Latest News

New research results show deadly asbestos-related cancer slowed down

Australian scientists, inventors and surgeons worked together in ground-breaking research that has lead to the discovery of a way to slow down the growth of deadly asbestos-related cancer malignant pleural mesothelioma. The break-through underpins a clinical trial due to start in six weeks.

More than 10,000 Australians have died since the early 1980s, with more than 25,000 expected to die over the next four decades, because of mesothelioma, an asbestos-related cancer. The cancer can take up to 40 years to develop.

Read More

Prize for ADRI researcher

This year’s finals of the Concord Repatriation General Hospital Early Career Research Awards were held on 22nd and 29th of October at the ANZAC Research Institute. These yearly research prizes are co-sponsored by Concord Hospital and the ANZAC Research Institute and awarded to early career researchers who primarily undertake their work on…

Read More

Why worry about asbestos?

Asbestos is the generic term used for a number of silicate minerals with fibrous crystalline structures. For more than 4,500 years naturally occurring fibrous minerals have been used by humans for their flexibility, strength, chemical inertness and insulation qualities. The Romans used asbestos for its flame-retardant and insulation properties by…

Read More
Kim Mattock

Kim Mattock, receptionist

Kim Mattock joined the ADRI in April 2010 as the Receptionist/Administrative Assistant of the Asbestos Diseases Research Institute. Kim previously worked in varied administration roles and fields, both corporate and government. Joining ADRI is a return to the Concord Hospital campus for Kim; in a ‘previous life’ she worked for various…

Read More

Professor Ken Takahashi, Director

Professor Ken Takahashi is the Director of the Asbestos Diseases Research Institute (ADRI), University of Sydney.  After graduating from the School of Medicine, Keio University (Japan) and accomplishing clinical residency, he moved to the University of Occupational and Environmental Health, Japan. There he studied and worked for 31 years including…

Read More
Justin Crosbie

Justin Crosbie, IT officer

Justin Crosbie joined ADRI in 2009 as the Information Systems Manager. He has completed a Science degree in Information Technology at the University of Technology, Sydney. Justin has previous experience working an information technology consultancy firms and also works for the ANZAC Research Institute on the Concord Campus.

Read More
Anne Warby

Anne Warby, research officer

Anne Warby joined the ADRI in 2013 as a research officer working with Dr Steven Kao. She is responsible for the coordination of two research studies, one investigating chemotherapy utilisation for patients with malignant mesothelioma, and the other a quality of life study in patients with malignant pleural mesothelioma. Anne…

Read More
Kan Chen

Kan Chen, biobank officer

Kan joined ADRI as a Biobank Officer in 2013 on a part-time basis to assist with the management, maintenance and development of the tissue bank. He has completed his undergraduate degree of Medical Science at the University of Sydney and worked in a blood bank for a private company. Recently…

Read More
Jenny Weismantel

Jenny Weismantel, volunteer

Jenny Weismantel joined the ADRI in 2011 as a Volunteer through the Concord Hospital Volunteers. Jenny has a Bachelor of Business in accounting and has assisted the Administration Team in many tasks including the development of the grants calendar and cataloguing of samples from the Australian Mesothelioma Surveillance Program. Jenny…

Read More
Anthony Linton

Dr Anthony Linton, clinical research fellow

Dr Anthony Linton is a medical oncologist at Concord Repatriation General Hospital and the Northern Cancer Institute St Leonards, specialising primarily in thoracic malignancies including malignant pleural mesothelioma and lung cancer. Dr Linton undertakes rural outreach clinics at Dubbo Base Hospital and is a senior clinical lecturer at the University…

Read More